# reload+after+2024-01-22 05:46:23.568065
address1§Room 325, 55 Claverick Street
city§Providence
state§RI
zip§02903
country§United States
phone§401 444 7375
website§https://www.oceanbiomedical.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome. It is also developing three product candidates based on the WPDS platform, including a malaria vaccine candidate; a humanized mAb malaria therapeutic candidate targeting Plasmodium falciparum glutamic-acid-rich protein (PfGARP); and a small molecule malaria therapeutic candidate targeting PfGARP. The company is based in Providence, Rhode Island. Ocean Biomedical, Inc. operates as a subsidiary of Poseidon Bio, LLC.
companyOfficers§[{'maxAge': 1, 'name': 'Ms. Elizabeth  Ng M.B.A.', 'age': 66, 'title': 'CEO & Director', 'yearBorn': 1957, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Gurinder Singh Kalra M.B.A.', 'age': 57, 'title': 'CFO & Treasurer', 'yearBorn': 1966, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Inderjote  Kathuria M.B.A., M.D.', 'age': 56, 'title': 'Chief Strategy Officer', 'yearBorn': 1967, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Daniel  Behr M.B.A.', 'age': 65, 'title': 'Executive VP, Head of External Innovation & Academic Partnerships and Secretary', 'yearBorn': 1958, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Chirinjeev Baboo Kathuria M.B.A., M.D.', 'age': 58, 'title': 'Founder & Executive Chairman of the Board', 'yearBorn': 1965, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Jack A. Elias M.D.', 'age': 72, 'title': 'Founder, Chairman of Scientific Advisory Board & Independent Director', 'yearBorn': 1951, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Jonathan  Kurtis M.D., Ph.D.', 'age': 55, 'title': 'Founder, Chairman of Scientific Advisory Board & Director', 'yearBorn': 1968, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Robert John Sweeney', 'age': 58, 'title': 'Chief Accounting Officer & Assistant Secretary', 'yearBorn': 1965, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Kevin  Kertscher', 'title': 'Communications Director', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§-0.315
currency§USD
dateShortInterest§1702598400
forwardEps§-0.89
exchange§NCM
quoteType§EQUITY
shortName§Ocean Biomedical, Inc.
longName§Ocean Biomedical, Inc.
firstTradeDateEpochUtc§1636381800
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§3912ca55-c0cf-3bf3-81ae-9047b9a5b9b3
gmtOffSetMilliseconds§-18000000
targetHighPrice§18.5
targetLowPrice§16.4
targetMeanPrice§17.45
targetMedianPrice§17.45
recommendationMean§2.0
recommendationKey§buy
numberOfAnalystOpinions§2
quickRatio§0.044
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
